Capricor Therapeutics, Inc.

NASDAQ:CAPR

Biotechnology

Healthcare
$8.03 -0.50%

-$0.14 today

Market cap
$465.03M
Beta
0.37
P/E (TTM)
-13.9
EPS (TTM)
-$2.00
52W Low $4.30High $40.37

Volume 8.33M

Average 1.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$355.95M

FY 2025 · Annual

+108.8% YoY

Liabilities

$50.16M

FY 2025 · Annual

+100.5% YoY

Equity

$305.79M

FY 2025 · Annual

+110.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents34.89M9.6M14.69M11.29M287.85M
Short-term Investments031.82M24.79M140.23M30.28M
Net Receivables391.75K547.58K10.37M10.37M59.17K
Inventory00000
Other Current Assets0919.89K000
Total Current Assets36.44M42.89M50.86M163.39M322.94M
Property, Plant & Equipment (Net)4.62M6.94M7.61M6.87M18.31M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets275.72K268.17K268.17K221.7K14.7M
Total Non-current Assets4.89M7.21M7.88M7.1M33.01M
Total Assets41.33M50.09M58.73M170.48M355.95M
Account Payables3.72M4.83M6.24M3.28M1.65M
Short-term Debt417.63K682.04K749.11K834.8K3.62M
Tax Payables00000
Deferred Revenue017.98M24.27M12M12M
Other Current Liabilities0002.36M11.85M
Total Current Liabilities4.13M23.59M31.27M21.03M35.84M
Long-term Debt3.38M3.38M3.38M3.38M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)09.47M000
Other Non-current Liabilities00000
Total Non-current Liabilities5.83M14.72M4.86M3.99M14.32M
Total Liabilities9.96M38.31M36.13M25.02M50.16M
Common Stock24.19K25.24K31.15K45.58K57.37K
Retained Earnings(108.06M)(137.08M)(159.37M)(199.83M)(304.88M)
Accumulated OCI0105.24K235.81K1.03M283.15K
Other Stockholders Equity(0)0100
Minority Interest00000
Total Equity31.37M11.79M22.6M145.46M305.79M
Total Debt6.25M5.94M5.61M4.83M17.94M
Net Debt(28.64M)(3.67M)(9.08M)(6.46M)(269.9M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$105.4M
Short-term Investments$173.2M
Other Current$4.5M
Total Current Assets$283.1M
PP&E (Net)$41.7M
Other Non-current$1.5M
Total Non-current Assets$43.2M
Total Assets$326.3M

Analysis

Selected assets total $326.3M for Latest. The largest visible component is Short-term Investments at $173.2M, about 53.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
SC 13G/ASC 13G/A filingOct 14, 2026
SC 13GSC 13G filingSep 14, 2026

How much cash does CAPR have?

Capricor Therapeutics, Inc. (CAPR) reported $287.85M in cash and equivalents in fiscal 2025.

How much debt does CAPR carry?

Capricor Therapeutics, Inc. (CAPR) reported $17.94M of total debt, with net debt of -$269.90M.